Lv71
5000 积分 2022-08-29 加入
SSGJ-613 Alleviates Pain and Reduces the Risk of Acute Flares in Patients With Gout: A Randomized, Double-Blind, Phase II Study
7小时前
已完结
Comparative effectiveness and predictors of SRI‑4 and LLDAS attainment in active systemic lupus erythematosus: a real‑world study of telitacicept versus belimumab
1个月前
已完结
Telitacicept targets Gd-IgA1 and autoantibody-producing B cells in IgA nephropathy
7个月前
已完结
Efficacy and Safety of Telitacicept in Adult IgA Vasculitis Nephropathy
7个月前
已完结
Efficacy and safety of telitacicept in patients with class III-V lupus nephritis: A real-world retrospective cohort study
7个月前
已完结
Real world data on dual BLyS/APRIL inhibition with telitacicept for lupus nephritis
7个月前
已完结
Telitacicept as a New Therapeutic Avenue for Generalized Myasthenia Gravis and Thymoma-Associated Myasthenia Gravis
7个月前
已完结
Effectiveness and safety of telitacicept in patients with systemic lupus erythematosus: a single center, retrospective, real-world study
7个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
11个月前
已完结
Safety and efficacy of telitacicept in refractory childhood-onset systemic lupus erythematosus: A self-controlled before-after trial
1年前
已完结
皖公网安备34019202002308
